OTCMKTS:ARSSF Assura (ARSSF) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free ARSSF Stock Alerts $0.48 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$0.48▼$0.4850-Day Range$0.48▼$0.5452-Week Range$0.48▼$0.68VolumeN/AAverage Volume3,125 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Get Assura alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Assura Stock (OTCMKTS:ARSSF)Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion. At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.Read More ARSSF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ARSSF Stock News HeadlinesMarch 22, 2024 | msn.comCaisse maladie: Assura va payer les factures médicalesMarch 21, 2024 | msn.comAssura a pris une décision radicale pour les factures de ses assurésApril 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 20, 2024 | msn.comLes clients d'Assura n'auront plus besoin d'avancer l'argent de leurs fraisMarch 20, 2024 | msn.comSanté: Assura ne demande plus à ses clients d'avancer leurs fraisFebruary 8, 2024 | lse.co.ukAssura sees significant demand for high-quality healthcare buildingsJanuary 24, 2024 | realmoney.thestreet.comPanmure Gordon gets more bearish on Assura, downgrades sharesDecember 3, 2023 | msn.comUK-listed healthcare firm Assura buys Wicklow healthcare centre and seeks to expandApril 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.December 2, 2023 | msn.comNewark Town Council backs Assura Aspire Limited plans to turn Woods Court into a medical centre for Barnbygate Surgery, NewarkNovember 16, 2023 | lse.co.ukAssura says NHS waiting lists due to buildings "not fit for purpose"October 9, 2023 | lse.co.ukAssura delivers strong half-year growth and refinances credit facilityOctober 9, 2023 | marketwatch.comAssura 1H Annualized Rent Rose on Portfolio Expansion; Refinances Credit FacilityOctober 9, 2023 | msn.comAssura expands primary care property portfolio as rents near £150mSeptember 21, 2023 | msn.comRuedi Bodenmann est «désolé»: Le directeur d'Assura s'excuse après des retards de remboursementSeptember 20, 2023 | msn.comLe patron d'Assura présente ses excuses après des retards de remboursementJuly 24, 2023 | lse.co.ukAssura starts GBP11 million NHS ambulance hub developmentJuly 6, 2023 | lse.co.ukAssura notes strong growth pipeline, raises quarterly dividendJuly 6, 2023 | marketwatch.comAssura Completed Multiple Projects in 1QJune 29, 2023 | lse.co.ukAssura touts 100th development with completion of medical centreJune 5, 2023 | msn.comAssura to relocate headquarters from Warrington to Greater ManchesterMay 24, 2023 | msn.comPeel Hunt Limited Reiterates Assura (LSE:AGR) Buy RecommendationMay 23, 2023 | lse.co.ukAssura swings to annual loss after valuation movement; outlook hopefulJanuary 16, 2023 | lse.co.ukAssura property portfolio and annualised rent roll fall in 2022November 22, 2022 | msn.comAssura profits plummet as boss blames interest rate rises and 'unhelpful' economic backdropNovember 22, 2022 | msn.comProperty developer Assura sees profits dive amid interest rates hikesNovember 22, 2022 | marketwatch.comAssura 1H Pretax Profit Fell; Warns About Lower Investment Activity AheadSee More Headlines Receive ARSSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Assura and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorReal Estate Industry REIT - Healthcare Facilities Sub-IndustryN/A Current SymbolOTCMKTS:ARSSF CUSIPN/A CIKN/A Webwww.assuraplc.com Phone44-1925-420660FaxN/AEmployees86Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Jonathan Stewart Murphy ACA (Age 52)MBA, CEO & Executive Director Comp: $1.07MMs. Jayne Marie Cottam (Age 50)CFO & Executive Director Comp: $602.87kMr. Robert JamesInterim Chief Investment OfficerMs. Joanne CullenSenior Management AccountantMr. David PurcellInvestor Relations DirectorMs. Orla BallGeneral CounselMs. Debbie ChalcraftGroup Compliance ManagerMs. Sarah TaylorChief People OfficerMs. Francesca HarrisInterim Head of CommunicationsPaul WarwickDirector of Sustainability & ProjectsMore ExecutivesKey CompetitorsAedifica NV/SAOTCMKTS:AEDFFHealthcare TrustNASDAQ:HTIBPHealthcare TrustNASDAQ:HTIANorthWest Healthcare Properties Real Estate Investment TrustOTCMKTS:NWHUFPrimary Health PropertiesOTCMKTS:PHPRFView All Competitors ARSSF Stock Analysis - Frequently Asked Questions Should I buy or sell Assura stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Assura in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ARSSF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ARSSF, but not buy additional shares or sell existing shares. View ARSSF analyst ratings or view top-rated stocks. How have ARSSF shares performed in 2024? Assura's stock was trading at $0.65 at the beginning of the year. Since then, ARSSF shares have decreased by 25.5% and is now trading at $0.4840. View the best growth stocks for 2024 here. How do I buy shares of Assura? Shares of ARSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ARSSF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryI’m afraid WWIII is a very real possibility Porter & Company"The Biggest Drug Ever" Is ComingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Assura Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
